ASSOCIATION FOR ACCESSIBLE MEDICINES

• ASSOCIATION FOR ACCESSIBLE MEDICINES $5,570,000 In-house, the client's own filings · 7 filings
• RUBIN, TURNBULL & ASSOCIATES $500,000 Outside firm · 5 filings
• FOLEY & LARDNER LLP $480,000 Outside firm · 8 filings
• THE GIBSON GROUP, LLC $330,000 Outside firm · 7 filings
• SQUIRE PATTON BOGGS $170,000 Outside firm · 7 filings
• FEROX STRATEGIES $140,000 Outside firm · 4 filings
• TWINLOGIC STRATEGIES, LLP $110,000 Outside firm · 4 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• S. 1041 (119th Congress)
  Affordable Prescriptions for Patients Act
  14 filings
• S. 1096
  Preserve Access to Affordable Generics and Biosimilars Act
  14 filings
• S. 1040
  Drug Competition Enhancement Act
  11 filings
• S. 43
  Skinny Labels, Big Savings Act
  7 filings
• H.R. 1843
  To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
  6 filings
• H.R. 3152
  Patent Eligibility Restoration Act of 2025
  6 filings
• H.R. 3160
  PREVAIL Act
  6 filings
• H.R. 3269
  ETHIC Act
  6 filings
• S. 1302
  Increasing Transparency in Generic Drug Applications Act
  6 filings
• S. 1414
  Expedited Access to Biosimilars Act
  6 filings
• S. 1546
  Patent Eligibility Restoration Act of 2025
  6 filings
• S. 1553
  PREVAIL Act
  6 filings
• H.R. 1051
  To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug applic…
  5 filings
• H.R. 4132
  Prescription Information Modernization Act of 2025
  5 filings
• S. 1954
  Biosimilar Red Tape Elimination Act
  5 filings
• S. 2027
  Prescription Information Modernization Act of 2025
  5 filings
• S. 2276
  ETHIC Act
  5 filings
• H.R. 1396
  PILLS Act
  4 filings
• H.R. 5526
  Biosimilar Red Tape Elimination Act
  4 filings
• H.R. 5811
  Restoring America’s Leadership in Innovation Act of 2025
  4 filings
• H.R. 6485
  Skinny Labels, Big Savings Act
  4 filings
• S. 1784
  MAPS Act
  4 filings
• S. 3469
  BIOSECURE Act of 2025
  4 filings
• S. 1041 (118th Congress)
  Restoring Overtime Pay Act of 2023
  3 filings
• H.R. 3955
  RAPID Reserve Act
  3 filings
• H.R. 4191
  MAPS Act
  3 filings
• S. 1097
  Interagency Patent Coordination and Improvement Act of 2025
  3 filings
• S. 1891
  PILLS Act
  3 filings
• S. 2062
  RAPID Reserve Act
  3 filings
• S. 2658
  Medication Affordability and Patent Integrity Act
  3 filings

• 2026 $3,640,000 22 filings
• 2025 $3,660,000 20 filings

• Trade (domestic/foreign) 29
• Pharmacy 24
• Copyright/Patent/Trademark 21
• Health Issues 16
• Manufacturing 8
• Labor Issues/Antitrust/Workplace 7
• Medicare/Medicaid 7
• Budget/Appropriations 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 27
• SENATE 25
• White House Office 20
• U.S. Trade Representative (USTR) 13
• Health & Human Services, Dept of (HHS) 11
• Centers For Medicare and Medicaid Services (CMS) 10
• Commerce, Dept of (DOC) 8
• Food & Drug Administration (FDA) 6
• Natl Economic Council (NEC) 6
• Federal Trade Commission (FTC) 5
• U.S. Customs & Border Protection 5
• Congressional Budget Office (CBO) 4
• Office of Management & Budget (OMB) 4
• Drug Enforcement Administration (DEA) 3
• Justice, Dept of (DOJ) 1
• Office of Science & Technology Policy (OSTP) 1
• Office of the Vice President of the United States 1
• Patent & Trademark Office (PTO) 1
• State, Dept of (DOS) 1